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B and T lymphocytes specifically recognize antigens by means of surface receptors
(surface immunoglobulins [sIg] and TCR [1], respectively) that represent the mo-
lecular product of multiple rearranging genes (2). Other lymphoid cells that lack
both sIg and TCR, are generally thought to be unable to recognize antigen(s), but
express "nonspecific" cytolytic activity against different types of tumor target cells
(3). An important function of CD3 + T lymphocytes is the ability to recognize for-
eign MHC molecules expressed by allogeneic cells. For example, in mixed lympho-
cyte cultures (MLC), CD3+ lymphocytes proliferate in response to allogeneic cells
and acquire the ability to specifically lyse target cellsbearing the stimulating alloan-
tigens (4-6). These events depend not only on the ability to specifically recognize
foreign MHC molecules, but also on the production ofgrowth factors allowing prolifer-
ation of cytolytic precursors (CTL-P). In this paper we show that TCR/CD3 - pe-
ripheral blood cell populations acquire the ability to lyse specific allogeneic target
cells after activation in MLC, in the presence of exogenous IL-2. Cloned CD3- cells
displaying a selective cytolytic pattern did not express detectable surface TCRa/ß
or y/S molecules and lacked productive mRNA for TCR a and ß chains. Small
amounts of TCRy mRNA were detectable in one of four clones tested . mRNA
for CD3 y and S chains were undetectable in all clones, whereas CD3 s mRNA was
consistently present (7).
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Materials and Methods
BriefDefinitive Report
Isolation of CD3- 4- 8- Lymphocytes, MLC, Cell Cloning and Evaluation of Cytolytic Activity.
Peripheral blood lymphocytes derived from normal donors were isolated by Ficoll-Hypaque
(RH) gradients and cells were then incubated with a mixture of anti-CD3 (OKT3, Ortho
Pharmaceuticals, Raritan, NJ), anti-CD4 (HP26), and anti-CD8 (B9.4) mAbs followed by
treatment with rabbit complement for 1 h at 37°C. Viable cells were isolated by F-H gra-
dients and cultured in microwells (5 x 104 cells/well) in the presence of autologous or al-
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logeneic irradiated feeder cells; after 4 d the cultures were supplemented with 100 U/ml of
rIL-2. The MLC-derived cells were cloned under limiting dilution conditions in the presence
of allogeneic irradiated feeder cells and 100 U/ml of rIL-2. 10 d later the cytolytic activity
was tested in a 4-h "Cr-release assay, in which varying numbers of effector cells were tested
against one or another of the following target cells: NK-sensitive K562 cells, PHA blasts de-
rived from the same source of lymphocytes used as stimulating cells in MLC, or from autolo-
gous or unrelated lymphocytes. PHA blasts were obtained by culturing PBL for 4 d with
0.5° Io PHA (vol/vol) in the presence of rIL-2 (100 U/ml). In all instances, target cells were
used at 5 x 103/well, for a final E/T cell ratio ranging between 25 :1 and 1.5:1 . Percent of
specific lysis was determined as previously described (6).
Flow Cytofluorometric Analysis.
￿
105 cells were stained with the appropriate mAb followed
by fluoresceinated goat anti-mouse Ig. Control aliquots were stained with the fluorescent
reagent alone. All samples were then analyzed on a flow cytometer (FAGS II, Becton Dick-
inson & Co., Mountain View, CA) gated to exclude nonviable cells. Results are expressed
as arbitrary normalized fluorescence histograms, i.e., number ofcellsvs. fluorescence inten-
sity. The mAbs used in these studies were represented by anti-Leu-4 (anti-CD3, Becton Dick-
inson & Co.), WT31 (directed to the TCR complex expressed by TCRa/0-bearing cells;
Sambio, Uden, The Netherlands), BB3 (directed to the disulphide-linked form of TCR-y/8)
(8), 8TCS-1 (directed to the 8 chain of non-disulphide-linked TCRy/S) (9), and MAR 206
(anti-CD2).
Northern Blot Analysis.
￿
Total cellular RNA was extracted from frozen cell pellets by the
guanidine thiocyanate method and purified by centrifugation through a CsCl gradient. RNA
was size fractionated by electrophoresis in a 1.5% agarose gel containing formaldehyde and
was transferred by capillary suction to a charged Nylon membrane in 1.5 M NaCl, 0.15 M
sodium citrate. Hybridization of the filters with 32P-labeled DNA probes and the washing
of the filters were performed as previously described (7). The DNA probes were a 1.1-kbEco
RI fragment of the TCRa cDNA clone pY14, a 0.77-kb Pst I fragment of the TCR-P cDNA
clone JUR-p2, a 1.6-kb Eco RI fragment of the TCR-y cDNA clone HGP02, a 0.7-kb Eco
RI fragment of the CD3-y cDNA clone pj6T3y-2, two 30-mer oligonucleotides overlapping
by 10 complementary bases corresponding to a CD3 8 cDNA (GAGGGAACGGTGGGAA-
CACTGCTCTCAGGAC and CCCAGGTCCAGTCTTGTAATGTCTGAGAGC) and two
30-mer oligonucleotides overlapping by 10 complementary bases corresponding to a CD3
e cDNA (CCCAGAGGAAGCAAACCAGAAGATGCGAAC and GCCCTCAGGTAGAGA-
TAAAAGTTCGCATCT). Exposure times were 2 d at -70 C.
Results and Discussions
Cell populations enriched in CD3 - lymphocytes were obtained by treatment of
nonadherent PBL with mAbs directed to CD3, CD4, and CD8 molecules. The
resulting populations were CD3-, CD4-, and CD8 -, expressed CD2 (N70%), CD7
(80%), and Leul9 (ti75%) and contained N20° / of sIg+ and B1 + cells (as detected
by indirect immunofluorescence and microscopical examination).
Cells were cultured in the presence of y-irradiated (5,000 rad) allogeneic mono-
nuclear cells. At day 4, in a group of cultures, 100 U/ml rIL-2 were added and
cultures continued for additional 8-12 d. The resulting cells were tested for their
ability to lyse "Cr-labeled PHA-induced blasts derived from the allogeneic stimu-
lating cells or from autologous or unrelated allogeneic cells. Fig. 1 shows that spe-
cific allogeneic cells were efficiently lysed, whereas no activity could be detected
against the other target cells, even at high lymphocyte/target ratios. Although not
shown, cell proliferation and generation ofcytolytic activity were strictly dependent
on the addition of exogenous IL-2. The observed cytolytic activity could be ex-
plained by the presence of (alloreactive) CD3+ cells contaminating the original re-
sponding lymphocyte populations and progressively outgrowing CD3- cells duringW
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culture. This possibility was ruled out by thedemonstration that thecytolytic popu-
lationsneitherreactedwith a panel ofanti-CD3 mAbs (Leu4, OKT3, UCHT1, JT3)
norboundmAbs specific for different types ofTCR (WT31, STCS-1 or BB3 mAbs)
(8-9), as detected by FAGS analysis (Fig. 2,4). Thus, the surface phenotype ofthese
MLC-derived cells was the following: CD7+CD2+CD3- sIg-B1 - . Parallel control
cultures of CD3- cells cultured (in IL-2) in the absence of stimulating cells or in
thepresence ofautologous irradiated cells, proliferated considerably less (not shown)
and, more importantly, didnot result in generation ofcytolyticactivity either against
autologous or allogeneic target cells (Fig. 1). Therefore, the generation of specific
cytolytic activity against allogeneic cells dependsnot only on the availability of IL-2,
but also on the delivery of a specific stimulus provided by allogeneic cells. On the
otherhand, comparable levels of cytolytic activity against K562 cells were detected
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FIGURE 1.
￿
MLC-activated CD3- lymphocytes specifically
lyse allogeneic target cells. Cells were stimulated in MLC
and tested for cytolytic activity against different "Cr-
labeledPHA-induced blasts or K562 target cells. (A)CD3-
cells that hadbeen cultured with the allogeneic cells "a°lysed
only target cells "a"("), butnotunrelatedallogeneic target
cells "b°(/)or autologous cells (A). (B) Thesamecell popu-
lation, afterculture in the presence ofautologous lympho-
cytes, wasunable to lyse autologous or allogeneic target cells.
On theotherhand,lysisofK562 occurred independent on
the autologous or allogeneic stimulus provided (p).
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FIGURE 2.
￿
Surface antigens expressed by a MLC-activated CD3- lymphocyte population (A)
and two representative clones with specific cytolytic activity against allogeneic PHA-blasts. (B)
Clone G10; (C) clone H12.2406
￿
CICCONE ET AL.
￿
BRIEF DEFINITIVE REPORT
in MLC-derived CD3- cells regardless of the origin (autologous or allogeneic) of
the stimulating cell population (Fig. 1).
We next analyzed clones derived from MLC-stimulated CD3- cells. These clones
were screened on thebasisof their ability to lyse specific allogeneic target cells (used
as stimulator in MLC). Table I shows agroup ofrepresentative clones obtained from
four different individuals. It is evident that all such clones expressed neither CD3
nor TCR molecules at the cell surface (Fig. 2, B and C), nevertheless, they lysed
specific target cellsbut notunrelatedallogeneic or autologous blastcells. K562 target
cellswere highly susceptible to lysis, whereas NK-resistant freshmelanoma cells dis-
played variable susceptibility to lysis. A further evidence that lysis of specific target
cells was not mediated by conventional CD3/TCR molecules was provided by the
findingthat mAbs directed to CD3 molecules failed to inhibit (orenhance) the specific
target cell lysis; on the other hand, the same mAbs blocked the specific target cell
lysis mediated by conventional CTLs (not shown). The failure of anti-CD3 or anti-
TCR mAbs to bind to the cells examined does not rule outthe possibility that these
molecules may be expressed at the cell surface. Indeed they may be expressed in
a molecular configuration that would not be recognized by conventional anti-CD3
mAbs. We therefore examined whethermRNA fordifferent chains ofCD3 or TCR-
a, -R, and -y chains could be detected in cloned alloreactive CD3- cells. No mRNA
for TCR-a and a truncated (1 kb) form of TCR R chains were detected in the four
clones analyzed (two representative clones are shown in Fig. 3). mRNA for the TCRy
chain was absent in three clones and detectable in small amounts in one (Fig. 3).
No mRNA for CD3 y and Schains couldbe detected, whereas high levels ofmRNA
forthe schainwere consistently present (7). These data furthersupport the concept
that no conventional CD3 or TCR molecules are surface expressed in CD3- cells
capable of specific lysis of allogeneic cells.
TABLE I
Cytolytic Activity of Allogeneic MLC-derived CD2* CD3- Clones
Results are expressed as percent of specific S~Cr release at a lymphocyte/target
cell ratio of N3 :1 .
"Cr-labeled target cells
Specific Unrelated Fresh
Autologous allogeneic allogeneic melanoma
Clone PHA-blasts PHA-blasts PHA-blasts K562 cells
E6 1" 86 1 73 25
E13 0 43 0 74 13
E19 0 37 0 74 8
E35 5 75 ND 53 11
E26 1 80 1 ND ND
E5 0 57 ND 81 ND
C8 0 100 0 ND 35
H12 0 85 0 51 26
G10 0 48 0 89 31
D5 0 63 0 78 4
E3 0 62 0 100 100
E4 0 100 2 100 86
E29 0 57 4 100 48CICCONE ET AL .
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Northern blot anal-
ysis of TCR and CD3 gene
products in two representative
CD3- clones with specific cyto-
lytic activity against allogeneic
blasts bearing the stimulating
alloantigens . (Lane 1) clone
H12 ; (lane 2) clone C10 ; (lane
3) Peer leukemic cell line; and
(lane 4) Jurkat leukemia . The
blots were hybridized to the
TCRa, -ß, -y, and to CD3 y,
S, and e probes .
While the ability to generate Gß3' lymphocytes capable of specific lysis of al-
logeneic cells has been repeatedly demonstrated in all four normal donors tested,
not all individuals were equally able to act as stimulators. Thus, only 2 of 10 stimu-
lators efficiently induced CD3- cell proliferation and cytolytic activity.
The molecular basis of specific target cell lysis mediated by CD3 - cells remains
obscure at the present . Our data arecompatible with the hypothesis ofthe presence
of surface receptor molecules, perhaps displaying a limited variability, capable of
recognizing allelic determinants (non-MHC-encoded?) expressedby allogeneic cells .
Whatever the explanation would be, the finding that (at least certain) CD3 - lym-
phocytes can specifically recognize andlyse allogeneic cells may have importantim-
plications in transplantation and the possibility of "in vivo" responses mediated by
CD3` lymphocytes should be carefully explored .
Summary
Human CD3- lymphocyte populations were obtained by treating peripheral
blood lymphocytes with mAbs directed to CD3, CD4, andCD8 surface antigens .
The resulting populations were cultured with irradiated allogeneic cells; at day 4,
100Ulml IL-2 were added and cultures continued foran additional 10d. Theresulting
populations were CD3-CD2+CD7+ and displayed cytolytic activity against PHA-
induced blast cells bearing the stimulating alloantigens but not against autologous
or unrelated allogeneic blast cells . When CD3- populations were cultured with ir-
radiated autologous cells, no cytolytic activity could be detected either against au-
tologous or allogeneic blast cells . On the other hand, K562 target cells were lysed2408
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by both MLC-derived CD3- cell populations regardless of the origin (autologous
or allogeneic) of the stimulating cells. CD3 - clones were further derived from
MLC-stimulated CD3 - populations. These clones displayed a cytolytic pattern
similar to the original MLC populations as only specific PHA blasts could be lysed.
These clones did not express detectable surface TCRa/R or -y/S molecules and lacked
productive mRNA for TCR a and R chains, while small amounts of TCRy mRNA
were detectable in one of four clones tested. Also mRNA for CD3 y and S chains
were undetectable in all clones, however, CD3 e mRNA was consistently present.
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